|
|
| Line 1: |
Line 1: |
| __NOTOC__
| |
| {{Coronary artery bypass surgery}}
| |
| {{CMG}}; {{AOEIC}} {{VK}}
| |
|
| |
|
| ==ACCF/AHA Guidelines for Hormonal Manipulation in Patients Undergoing CABG<ref name="pmid22064599">{{cite journal| author=Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG et al.| title=2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. | journal=Circulation | year= 2011 | volume= | issue= | pages= | pmid=22064599 | doi=10.1161/CIR.0b013e31823c074e | pmc= |url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22064599 }} </ref>==
| |
| {{cquote|
| |
| ===[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]]===
| |
| '''1.''' Use of continuous intravenous insulin to achieve and maintain an early postoperative blood glucose concentration less than or equal to 180 mg/dL while avoiding [[hypoglycemia]] is indicated to reduce the incidence of adverse events, including deep sternal wound infection, after CABG.<ref name="pmid12771873">{{cite journal |author=Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, Floten HS, Starr A |title=Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting |journal=[[The Journal of Thoracic and Cardiovascular Surgery]] |volume=125 |issue=5 |pages=1007–21 |year=2003 |month=May |pmid=12771873 |doi=10.1067/mtc.2003.181 |url=http://linkinghub.elsevier.com/retrieve/pii/S0022522303501052 |accessdate=2011-12-14}}</ref><ref name="pmid16608860">{{cite journal |author=Ingels C, Debaveye Y, Milants I, Buelens E, Peeraer A, Devriendt Y, Vanhoutte T, Van Damme A, Schetz M, Wouters PJ, Van den Berghe G |title=Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life |journal=[[European Heart Journal]] |volume=27 |issue=22 |pages=2716–24 |year=2006 |month=November |pmid=16608860 |doi=10.1093/eurheartj/ehi855 |url=http://eurheartj.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=16608860 |accessdate=2011-12-14}}</ref><ref name="pmid11794168">{{cite journal |author=van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R |title=Intensive insulin therapy in the critically ill patients |journal=[[The New England Journal of Medicine]] |volume=345 |issue=19 |pages=1359–67 |year=2001 |month=November |pmid=11794168 |doi=10.1056/NEJMoa011300 |url=http://dx.doi.org/10.1056/NEJMoa011300 |accessdate=2011-12-14}}</ref> ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''
| |
|
| |
| ===[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class III: HARM]]===
| |
|
| |
| Postmenopausal hormonal therapy ([[estrogen]]/[[progesterone]]) should not be administered to women undergoing CABG.<ref name="pmid9718051">{{cite journal |author=Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E |title=Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group |journal=[[JAMA : the Journal of the American Medical Association]] |volume=280 |issue=7 |pages=605–13 |year=1998 |month=August |pmid=9718051 |doi= |url=http://jama.ama-assn.org/cgi/pmidlookup?view=long&pmid=9718051 |accessdate=2011-12-14}}</ref><ref name="pmid12117397">{{cite journal |author=Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J |title=Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial |journal=[[JAMA : the Journal of the American Medical Association]] |volume=288 |issue=3 |pages=321–33 |year=2002 |month=July |pmid=12117397 |doi= |url=http://jama.ama-assn.org/cgi/pmidlookup?view=long&pmid=12117397 |accessdate=2011-12-14}}</ref><ref name="pmid16442114">{{cite journal |author=Ouyang P, Tardif JC, Herrington DM, Stewart KJ, Thompson PD, Walsh MN, Bennett SK, Heldman AW, Tayback MA, Wang NY |title=Randomized trial of hormone therapy in women after coronary bypass surgery. Evidence of differential effect of hormone therapy on angiographic progression of disease in saphenous vein grafts and native coronary arteries |journal=[[Atherosclerosis]] |volume=189 |issue=2 |pages=375–86 |year=2006 |month=December |pmid=16442114 |doi=10.1016/j.atherosclerosis.2005.12.015 |url=http://linkinghub.elsevier.com/retrieve/pii/S0021-9150(05)00838-5 |accessdate=2011-12-14}}</ref> ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''
| |
|
| |
| ===[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIb]]===
| |
|
| |
| The use of continuous intravenous insulin designed to achieve a target intraoperative blood glucose concentration less than 140 mg/dL has uncertain effectiveness.<ref name="pmid16256784">{{cite journal |author=Butterworth J, Wagenknecht LE, Legault C, Zaccaro DJ, Kon ND, Hammon JW, Rogers AT, Troost BT, Stump DA, Furberg CD, Coker LH |title=Attempted control of hyperglycemia during cardiopulmonary bypass fails to improve neurologic or neurobehavioral outcomes in patients without diabetes mellitus undergoing coronary artery bypass grafting |journal=[[The Journal of Thoracic and Cardiovascular Surgery]] |volume=130 |issue=5 |pages=1319 |year=2005 |month=November |pmid=16256784 |doi=10.1016/j.jtcvs.2005.02.049 |url=http://linkinghub.elsevier.com/retrieve/pii/S0022-5223(05)00368-5 |accessdate=2011-12-14}}</ref><ref name="pmid20216389">{{cite journal |author=Duncan AE, Abd-Elsayed A, Maheshwari A, Xu M, Soltesz E, Koch CG |title=Role of intraoperative and postoperative blood glucose concentrations in predicting outcomes after cardiac surgery |journal=[[Anesthesiology]] |volume=112 |issue=4 |pages=860–71 |year=2010 |month=April |pmid=20216389 |doi=10.1097/ALN.0b013e3181d3d4b4 |url= |accessdate=2011-12-14}}</ref><ref name="pmid17310047">{{cite journal |author=Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, O'Brien PC, Johnson MG, Williams AR, Cutshall SM, Mundy LM, Rizza RA, McMahon MM |title=Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial |journal=[[Annals of Internal Medicine]] |volume=146 |issue=4 |pages=233–43 |year=2007 |month=February |pmid=17310047 |doi= |url= |accessdate=2011-12-14}}</ref> ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''}}
| |
|
| |
| ==Guidelines Resources==
| |
| *2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery : A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines<ref name="pmid22064599">{{cite journal| author=Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG et al.| title=2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. | journal=Circulation | year= 2011 | volume= | issue= | pages= | pmid=22064599 | doi=10.1161/CIR.0b013e31823c074e | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22064599 }} </ref>
| |
|
| |
| ==References==
| |
| {{reflist|2}}
| |
|
| |
| {{WH}}
| |
| {{WS}}
| |
| [[Category:Cardiac surgery]]
| |
| [[Category:Cardiology]]
| |
| [[Category:Surgery]]
| |
| [[Category:Surgical procedures]]
| |
| [[Category:Up-To-Date]]
| |
| [[Category:Up-To-Date cardiology]]
| |